Cardiovascular disease morbidity/mortality are increasing due to an aging population and the rising prevalence of diabetes and obesity. Therefore, innovative cardioprotective measures are required to reduce cardiovascular disease morbidity/mortality. The role of necroptosis in myocardial ischemia–reperfusion injury (MI–RI) is beyond doubt, but the molecular mechanisms of necroptosis remain incompletely elucidated. Growing evidence suggests that MI–RI frequently results from the superposition of multiple pathways, with autophagy, ferroptosis, and CypD-mediated mitochondrial damage, and necroptosis all contributing to MI–RI. Receptor-interacting protein kinases (RIPK1 and RIPK3) as well as mixed lineage kinase domain-like pseudokinase (MLKL) activation is accompanied by the activation of other signaling pathways, such as Ca2+/calmodulin-dependent protein kinase II (CaMKII), NF-κB, and JNK-Bnip3. These pathways participate in the pathological process of MI–RI. Recent studies have shown that inhibitors of necroptosis can reduce myocardial inflammation, infarct size, and restore cardiac function. In this review, we will summarize the molecular mechanisms of necroptosis, the links between necroptosis and other pathways, and current breakthroughs in pharmaceutical therapies for necroptosis.
29 January 2025 in The International Journal of Artificial Organs
Cardiopulmonary bypass (CPB) is an indispensable technique in cardiac surgery; however, its impact on gut microbiota and metabolites remains insufficiently studied. CPB may disrupt the intestinal mucosal barrier, altering the composition and function of gut microbiota, thereby triggering local immune responses and systemic inflammation, which may lead to postoperative complications. This narrative review examines relevant literature from PubMed, Web of Science, Google Scholar, and CNKI databases over the past decade. Keywords such as “gut microbiota,” “cardiopulmonary bypass,” “cardiac surgery,” and “postoperative complications” were employed, with Boolean operators used to refine the search results. The review examines changes in gut microbiota before and after CPB, their role in postoperative complications, and potential strategies for modulation to improve outcomes.
The cardiac variant of Fabry disease (FD) has high rates of missed diagnosis and misdiagnosis due to the lack of systemic symptoms. Here, we report a case of a 68-year-old female with delayed-onset FD presenting as concentric left ventricular hypertrophy (LVH) with right bundle branch block, atrial fibrillation, and diastolic dysfunction, which was first presented with coronary artery spasm. Early cardiac-specific signs are crucial for diagnosing this disease due to the lack of extracardiac indications and the late onset of symptoms. This case raises a new red flag that patients with unexplained LVH and its atypical electrocardiographic (ECG) manifestations accompanied by diastolic dysfunction should be considered for FD. We also recommend further refinement of examinations associated with Fabry disease, which will contribute to the early diagnosis and treatment of the disease.
Background: Coarctation of the aorta (CoA) stenting can lead to late vascular complications, but Stanford type A aortic dissection years after Cheatham–Platinum (CP) stent implantation is exceptionally rare. We report a successfully managed case to discuss an effective surgical approach. Case: A 16-year-old female presented with sudden loss of consciousness caused by a substantial pericardial effusion. Seven years prior, she had undergone CP stent implantation for CoA. Aortic computed tomography angiography (CTA) revealed a penetrating ulcer in the anterior wall of the ascending aorta with an intramural hematoma, and intraoperative findings confirmed a Stanford type A aortic dissection. The patient underwent one-stage bypass grafting from the ascending to the descending aorta, aortic sinusoplasty, and ascending aorta replacement under cardiopulmonary bypass. The postoperative course was uneventful, and she was discharged in stable condition. Conclusions: One-stage bypass grafting combined with ascending aorta replacement and sinusoplasty provides a safe and effective treatment strategy for complex aortic dissections following CoA stenting. This surgical approach may be considered for a broader population of patients with similar presentations.
28 April 2026 in World Journal for Pediatric and Congenital Heart Surgery
Total anomalous pulmonary venous connection (TAPVC) is a rare congenital cardiac malformation, and cases complicated with airway stenosis are even less common, posing substantial diagnostic and therapeutic challenges. We report a 4-month-old male infant with supracardiac TAPVC, accompanied by left main bronchial stenosis, a central atrial septal defect (ASD), and severe pulmonary hypertension. Following supportive management, the patient underwent TAPVC repair and atrial septal defect patch repair. Intraoperatively, weaning from cardiopulmonary bypass initially failed due to severe pulmonary hypertension, but was successfully achieved after fenestration of the atrial septal patch for decompression. Postoperative imaging confirmed unobstructed pulmonary venous return, resolution of pulmonary hypertension, and relief of airway compression. At 6-month follow-up, the infant demonstrated normal growth and development. TAPVC with airway stenosis markedly increases perioperative risk, and thorough preoperative assessment with timely surgical intervention is essential for favorable outcomes.